期刊
JOURNAL OF IMMUNOLOGY
卷 188, 期 6, 页码 2477-2482出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1102398
关键词
-
类别
资金
- National Institutes of Health
- Juvenile Diabetes Research Foundation
MHC class II tetramers have emerged as an important tool for characterization of the specificity and phenotype ofCD4 T cell immune responses, useful in a large variety of disease and vaccine studies. Issues of specific T cell frequency, biodistribution, and avidity, coupled with the large genetic diversity of potential class II restriction elements, require targeted experimental design. Translational opportunities for immune disease monitoring are driving the rapid development of HLA class II tetramer use in clinical applications, together with innovations in tetramer production and epitope discovery. The Journal of Immunology, 2012, 188: 2477-2482.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据